1 Introduction: Deoxycholic Acid - From Endogenous Bile Acid to a Novel Drug Delivery Carrier
As an essential component of endogenous human bile acids, deoxycholic acid has demonstrated innovative value beyond its conventional applications in the field of drug delivery in recent years. Its unique amphipathic molecular structure endows it with remarkable capacity to form micelles and solubilize membrane proteins, a property that is being reinterpreted as an ideal feature for drug delivery carriers. In the development of novel nano-drug delivery systems, deoxycholic acid significantly improves the bioavailability of various poorly soluble drugs by conjugating with drug molecules or constructing delivery vehicles, offering new strategies to tackle longstanding formulation challenges in the pharmaceutical industry.
2 Molecular Mechanisms of Deoxycholic Acid for Enhancing Drug Absorption and Its Intelligent Delivery Properties
Molecular engineering studies have uncovered the sophisticated mechanisms by which deoxycholic acid facilitates drug absorption. The
distinctive combination of its rigid steroid skeleton and flexible side chain enables dynamic conformational changes in response to environmental pH, rendering it a critical building block for intelligent delivery systems. Experiments have verified that anticancer drugs modified with deoxycholic acid exhibit 3–5-fold higher stability in the gastrointestinal tract. Meanwhile, the bile acid transporter-mediated active absorption pathway elevates their oral bioavailability to more than twice that of conventional formulations. This biomimetic delivery strategy not only breaks the bottleneck of low bioavailability but also achieves targeted delivery for selected drugs.
3 Application of Deoxycholic Acid in Barrier-Crossing Delivery of Biopharmaceuticals
In the domain of biomacromolecular therapeutics, the membrane-permeation-enhancing effect of deoxycholic acid has sparked intensive research interest. Via covalent conjugation or physical encapsulation, deoxycholic acid assists macromolecules such as insulin and nucleic acid drugs in crossing multiple biological barriers. Latest studies reveal that deoxycholic acid-based siRNA delivery systems achieve hepatic gene silencing efficiency comparable to commercial transfection reagents, with markedly improved safety profile. This breakthrough provides a viable approach for non-viral delivery of gene therapy drugs, and several related formulations have advanced into clinical investigations.
4 Deoxycholic Acid as a Crystal Modulator in Pharmaceutical Crystallization Engineering
The application of deoxycholic acid in pharmaceutical crystallization engineering also merits attention. Acting as a crystal modifier, it can directionally regulate the growth habit and surface energy of drug crystals, thereby optimizing powder properties and dissolution behavior of drugs. With this technology, multiple poorly soluble drugs that previously required complicated formulation processes have been successfully formulated into simple tablets, cutting production costs by over 30%. More encouragingly, special crystal forms induced by deoxycholic acid frequently possess superior physical stability and tunable release profiles, opening up new avenues for the development of modified new drugs.
5 Structural Modification, Derivative Development and Intelligent Design of Deoxycholic Acid
Despite the promising performance of deoxycholic acid in drug delivery, substantial room remains for structural optimization. Researchers are developing a panel of structural analogues by introducing specific functional groups to modulate lipophilicity and reduce hemolytic activity. Such structural modifications preserve the core functions of deoxycholic acid while equipping it with new features including pH-triggered release and enzyme-mediated dissociation. The adoption of computational chemistry and artificial intelligence has greatly accelerated this optimization workflow, enabling custom design of deoxycholic acid derivatives tailored for specific delivery requirements.
6 Summary and Outlook
The transformation of deoxycholic acid from a digestive aid to a pivotal drug delivery moiety reflects the in-depth exploration and innovative repurposing of natural molecules in pharmaceutical science. With continuous advances in delivery technology, this endogenous molecule will undoubtedly play an increasingly important role in the development of innovative formulations. Future research will further explore its synergistic effects with other delivery technologies to address more intractable delivery hurdles and propel the pharmaceutical industry toward precision and intelligence.
